INS and Insulin resistance: Notably, this effect occurred in both diabetic and non-diabetic participants, suggesting that the improvement in insulin responsiveness following HBOT is not restricted to individuals with manifest diabetes but may also extend to overweight subjects at elevated risk of developing insulin resistance and T2DM [91].